Lim, K., Kutyna, M., Kalro, A., Hiwase, D., Thomas, D. (2025). Secondary Acute Myeloid Leukemia transformed from chronic myelomonocytic leukemia is strongly resistant to venetoclax but demonstrates sensitivity to anti-GM-CSF lenzilumab immunotherapy. Blood. https://doi.org/10.1182/blood-2025-1714